This is important with respect to the development of personalized medicine approaches, as it has been well described that the patient genetic background plays an important role in many liver diseases (e.g. alpha-1 antitrypsin deficiency, hemochromatosis, Wilson’s disease and response to HCV treatment; [46] and reviewed in [7, 47, 48]. The gene discussed is PSMA6; the disease is Wilson disease.